Skip to main content

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Search

1062 result(s) found, displaying 751 to 775
  • Australian Public Assessment Report for Regorafenib
  • Australian Public Assessment Report for Mirabegron
  • Australian Public Assessment Report for Dabrafenib mesilate
  • Australian Public Assessment Report for Eltrombopag olamine
  • Australian Public Assessment Report for Fentanyl citrate
  • Australian Public Assessment Report for Cobicistat
  • Australian Public Assessment Report for Elvitegravir
  • Australian Public Assessment Report for Ivacaftor
  • Australian Public Assessment Report for Retapamulin
  • Australian Public Assessment Report for Romidepsin
  • Australian Public Assessment Report for Fentanyl citrate
  • Australian Public Assessment Report for Ivermectin
  • Australian Public Assessment Report for Adalimumab (rch)
  • Australian Public Assessment Report for Interferon beta-1a
  • Australian Public Assessment Report for Pertuzumab (rch)
  • Australian Public Assessment Report for Nabiximols
  • Australian Public Assessment Report for Rivaroxaban
  • Australian Public Assessment Report for Botulinum toxin type A

Help us improve the Therapeutic Goods Administration site